Figure 2
The overall HRCT score at baseline and its changes at 6 months among survivors.
The baseline level did not significantly differ between the pirfenidone and control groups or the deceased and survivor groups.
Figure 2 | Scientific Reports
The overall HRCT score at baseline and its changes at 6 months among survivors.
The baseline level did not significantly differ between the pirfenidone and control groups or the deceased and survivor groups.
